Member Info for Techtonic

ON the wall.

I give up !

"is being misappropriated" .. mainly via predictive text!

Just out of interest because much of our language is being missing appropriated these days (And it bugs me!)

The phrase is one that has negative connotations..always.

"This expression comes from the Bible in which the prophet interprets some mysterious writing that a disembodied hand has inscribed on the palace wall, telling King Belshazzar that he will be overthrown."

But , hey, it's only meaning! We live in a world where it's okay to say 2+2=5 , its close enough.

Teacher of Tripe , TT

Been watching this from afar for a few months, waiting for the fundraise RNS. Feel sorry for long-term holders, but can't quite get my head around why people would buy in before a signalled Placing.

But on the subject of cashburn.

Apart from the very high BOD wages, where does this 400k/month come from? Is this R&D / manufacturing costs?

Seems very high

Firstly, apologies Mornington, if you've been here a long time.

Secondly , excellent RNS - they do appear to have turned this around.

Be interesting to know potential SA revenue

Nice little "ticks ups" matter not one jot. They either get FDA approval or massive dilution at discount to these prices .

Either one is coming. Everyone knows that.

Oh come on people!

Everyone news they needed a fundraiser it was going to be at a massive discount

Agree Sometime,

I think we've seen enough already understand how Ciz operate.

Seems they don't want to change their ways regarding communication

So it's have a punt / have faith and maybe wait several months to find out if you have wasted your money or got a deal.

I suspect in four months we'll be having this debate still

..waiting uneasily for an update..

How long do you wait?

Ps seems the MMs trying to drum up a bit of trade recently with a few ghost trades. (Pulled trades)

I don't know about bad taste..nobody's died.

But, yes, I agree, Vinc ..it was meant as a one-off discussion about the business to date..

Good that you've changed it. It did cross my mind, but I simply didn't notice the headline anymore while responding

Hello again Brond..😁nice to see you. Hope you're well.

Obviously we're all playing with different packs of cards.

Hey, steady on FF, you'll have Big Cheesy thinking I'm you as well as JoeBloggs!

Neil, you're a businessman.

The person who holds all the cards is the one with least to lose.

Ciz lose EVERYTHING with no deal. Yes they have IP , patents etc..

But they essentially start from scratch with a business plan.

BIO/Behnke : if it doesn't work for them they still walk away very rich people with successful businesses. Onwards and upwards to their next venture.

I'm not saying they don't want it, I'm just saying it's quite apparent who holds the cards here.

My take on it FF is that you can’t enter into a MOU without another party, so, by definition, it’s a signed agreement. Your further question - will there be further dilution and accretion of share price ?

If the MOU become a hard Contract with BIO there are bound to be many clauses and caveats along the lines of “If the test doesn’t reach X sensitivity in Y time with Z funds, then party has the right to end / modify agreement etc. If BIO cannot secure X interested parties (hospitals etc) it retains the right to end agreement etc etc.

And , ultimately, if BIO - or any part of that - pulls the plug and breaches contract, where does that leave CIZ? 5 years at International Arbitration, costly US Courts? No chance.

That’s why BIO all the cards. Ciz’ entire Raison D’etre is this test. It’s the sole reason fro being. The US side are already very high wealth people regardless of this deal, and Corepath a successful business - although I’m sure they would all love it to succeed from an ethical and financial perspective.

Big cheesy.

I advise what I always advise on message boards.

Play the ball, not the player.

I'm invested here and I'm not very happy about what's happened. So I've sold 4/5 of holding.

I won't be trading or buying more until this MOU turns into a contract.

If you have any thing of substances say please say it, but please refrain from assumptions of people are.

Invariably people are wrong. These boards are just full of witch hunts.

Stick to the investment case.

Jeez. I am not joeyBloggs!

I thought that would happen. It always does . Those that have been here a long time know that I'm not.

And in fact.

Joeybloggs - do me a favour and stop responding!

Joe nloggs

Mr Bloggs, I think calling AS a liar is a bit strong.

But it's hard to deny he doesn't present the full truth when it suits.

What's your definition of a lie, Highlandmatt?

The MO of Alan Syms appears to been when it's good news , inform the Market via RNS/ Video chat, but if it's negative don't bother - like promising to report back with an update from China last year, but didn't...is that a lie or is it just sloppy/negligent?

I suppose, as Highlandmatt says, it's up to individuals to decided what all this means and whether to hold or sell. Not ideal though.

Think about where this could be at led by a team with real business acumen and clout.

They could have used RNS updates and press / wider media to keep this bubbling circa £15-£20Million Market Cap as a base on potential alone.

(Which wouldn't have been out of the ordinary for a company with this potential)

It would have been in the common Psyche with more interest , and possibly bigger investors (more volume at least)

The subsequent fundraise would have been set at circa 5p rather than 2p.

The negotiating leverage with Bill Behnke's consortium at an MC of £20 Mill would have been much stronger .

The secrecy surrounding the product development is ridiculous as Patents and IP protect that side.

But instead of going all guns blazing, they've opted for control and misinformation in a negative way.

With a strong PR team , this could have been in a strong position now with a Market Cap base way above the present one .

Remember , the BoD now have misinformed about several things:

1)AS reporting back from China publicly. He said nothing (negative connotation)

2) he stated the product would hopefully be in the market in the "very near term". It isn't

3)The misleading wording about 'engaging in clinical trials'

4) Not needing a fundraise (with the potential of selling CDT shares), but producing a shock fundraise.

5) being way behind schedule from what they intimated.

All could have been SO much better and respectful to shareholders

On balance, I think the test will get to Market, but when, number of take-up, specificity/ sensitivity, final contract details are anyone's guess

Looks like Chris Hutch is getting a few trader mates on today ;o)

Hard to know where to go with this one with such infrequent news.

Could be one where they drop an amazingly good one about clinical trials/LFT/ breast cancer updates,

Or drop another out of the blue stinker that Bill and Co don't want to get the cash together.

Regarding Alan Miller -just another name that adds a fishy smell from a previous experience.

(Jace: See my post on Nuformix - a big 'leaked' article in the Times, cross pollination with several present staff at CDT, a rise in price and sell off by Alan Miller)

Fastfood - I doubt your theory is correct.

Mr Miller - I would rather not have seen his name, although I have no idea of his involvement here and no idea if he had anything to do with previous leak to The Times.

To be quite honest we could do with it a decent story in The Times! Certainly boosted the share price temporarily at Nuformix.

Like with most companies, some are privy to more information than others.

The days of block selling before funding RNS showed that . Happens everywhere; corrupt markets.

But it seems as far as Ciz is concerned, we will only be given crumbs of info when they like

Even the recent French MABS news release was simply re-tweeted .

As we've seen with this non-disclosure of 100kreceipt , Ciz is a secretive firm, unfriendly to shareholders.

I reckon when this one 120 day negotiation period is over, we won't hear a thing.

They'll leave the shareholders to guess and fumble around in the dark, asking questions, wondering if it's an investable company. From past experience I doubt they will inform about scaling up progress or start of clinical trials.

Very very difficult to understand an investment with no data updates.

I'd say it's not an investment, it's just a guess on a hunch.

Still in with my fifth, but it hasn't got a great feel about it.